Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1985 2
1986 1
1988 3
1989 4
1990 8
1991 2
1992 10
1993 6
1994 13
1995 20
1996 12
1997 22
1998 35
1999 39
2000 38
2001 35
2002 54
2003 69
2004 73
2005 105
2006 132
2007 123
2008 194
2009 220
2010 293
2011 365
2012 435
2013 534
2014 606
2015 743
2016 821
2017 898
2018 1066
2019 1345
2020 1705
2021 1883
2022 2243
2023 2109
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

14,566 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.
Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, Xu Y, He J, Lan J, Ou Q, Fang Y, Lu Z, Wu X, Pan Z, Peng J, Lin J. Li W, et al. Among authors: zhou c. Autophagy. 2023 Aug 29:1-17. doi: 10.1080/15548627.2023.2249762. Online ahead of print. Autophagy. 2023. PMID: 37615625
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. N Engl J Med. 2023 Oct 21. doi: 10.1056/NEJMoa2306441. Online ahead of print. N Engl J Med. 2023. PMID: 37870976
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.
Zhou C, Solomon B, Loong HH, Park K, Pérol M, Arriola E, Novello S, Han B, Zhou J, Ardizzoni A, Mak MP, Santini FC, Elamin YY, Drilon A, Wolf J, Payakachat N, Uh MK, Rajakumar D, Han H, Puri T, Soldatenkova V, Lin AB, Lin BK, Goto K; LIBRETTO-431 Trial Investigators. Zhou C, et al. N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870973
Expression patterns of claudins in cancer.
Tao D, Guan B, Li H, Zhou C. Tao D, et al. Among authors: zhou c. Heliyon. 2023 Oct 29;9(11):e21338. doi: 10.1016/j.heliyon.2023.e21338. eCollection 2023 Nov. Heliyon. 2023. PMID: 37954388 Free PMC article. Review.
Cellular senescence: a double-edged sword in cancer therapy.
Xiao S, Qin D, Hou X, Tian L, Yu Y, Zhang R, Lyu H, Guo D, Chen XZ, Zhou C, Tang J. Xiao S, et al. Among authors: zhou c. Front Oncol. 2023 Sep 12;13:1189015. doi: 10.3389/fonc.2023.1189015. eCollection 2023. Front Oncol. 2023. PMID: 37771436 Free PMC article. Review.
14,566 results
You have reached the last available page of results. Please see the User Guide for more information.